New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
10:00 EDTTSE, QIWI, MTX, ZPIN, SRPT, PTCT, ENPH, WPG, QSII, NEP, CSG, AXYS, ATNM, ABYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with an Equal Weight at Morgan Stanley... Actinium Pharmaceuticals (ATNM) initiated with a Buy at Canaccord... Axys Technologies (AXYS) initiated with a Buy at Dougherty... Chambers Street Properties (CSG) initiated with a Neutral at SunTrust... Enphase Energy (ENPH) initiated with a Buy at Dougherty... Minerals Technologies (MTX) initiated with an Outperform at Wedbush... NextEra Energy Partners (NEP) initiated with a Buy at BofA/Merrill... PTC Therapeutics (PTCT) initiated with a Buy at BofA/Merrill... QIWI (QIWI) initiated with a Positive at Susquehanna... Quality Systems (QSII) initiated with a Buy at Topeka... Sarepta (SRPT) initiated with a Neutral at BofA/Merrill... Trinseo S.A. (TSE) initiated with a Buy at BofA/Merrill... Washington Prime Group (WPG) initiated with a Neutral at SunTrust... Zhaopin (ZPIN) initiated with a Buy at UBS.
News For ABY;ATNM;AXYS;CSG;ENPH;MTX;NEP;PTCT;QIWI;QSII;SRPT;TSE;WPG;ZPIN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 23, 2015
17:08 EDTMTXMinerals Technologies reports Q1 adjusted EPS $1.07, consensus 99c
Subscribe for More Information
09:18 EDTPTCTOn The Fly: Pre-market Movers
Subscribe for More Information
07:51 EDTPTCTPTC Therapeutics price target raised to $155 from $135 at Oppenheimer
Oppenheimer increased its price target on PTC after the company, along with Roche (RHHBY), presented data on its RG7800 drug that the firm believes showed proof-of-mechanism in health subjects. The firm recommends owning PTC ahead of two events: the scheduled October 2015 P3 read-out of Translarna in DMD, and an update on the MOONFISH trial of RG7800 slated to occur in early 2016. The firm keeps an Outperform rating on the shares.
April 22, 2015
07:06 EDTATNMActinium to partner with Aplastic Anemia & MDS International Foundation
Subscribe for More Information
April 20, 2015
10:00 EDTZPINOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 58.com (WUBA) initiated with a Hold at Summit Research... Aduro Biotech (ADRO) initiated with a Buy at Roth Capital... Alibaba (BABA) initiated with a Buy at Summit Research... Baidu (BIDU) initiated with a Buy at Summit Research... Callaway Golf (ELY) initiated with a Buy at Jefferies... Cellectis (CLLS) initiated with a Buy at Jefferies... Changyou.com (CYOU) initiated with a Buy at Summit Research... Cheetah Mobile (CMCM) initiated with a Buy at Summit Research... Ctrip.com (CTRP) initiated with a Hold at Summit Research... Dynegy (DYN) initiated with an Overweight at Morgan Stanley... FMC Corporation (FMC) initiated with a Neutral at Monness Crespi... Franklin Financial Network (FSB) initiated with a Buy at BofA/Merrill... Granite Construction (GVA) initiated with an Outperform at Cowen... Hershey (HSY) initiated with a Reduce at Nomura... JD.com (JD) initiated with a Hold at Summit Research... Jumei (JMEI) initiated with a Buy at Summit Research... McEwen Mining (MUX) initiated with a Buy at H.C. Wainwright... Natural Gas Services (NGS) initiated with a Neutral at Sidoti... New Residential (NRZ) initiated with a Buy at BofA/Merrill... Platform Specialty Products (PAH) initiated with an Outperform at Credit Suisse... Qihoo 360 (QIHU) initiated with a Buy at Summit Research... Qunar (QUNR) initiated with a Buy at Summit Research... SINA (SINA) initiated with a Hold at Summit Research... Smith & Wesson (SWHC) initiated with a Sector Perform at RBC Capital... Sohu.com (SOHU) initiated with a Hold at Summit Research... SolarEdge (SEDG) initiated with a Buy at Deutsche Bank... Splunk (SPLK) initiated with a Buy at Citigroup... Tableau (DATA) initiated with a Neutral at Citigroup... Team Health (TMH) initiated with an Outperform at Leerink... Tuniu (TOUR) initiated with a Buy at Summit Research... Vipshop (VIPS) initiated with a Buy at Summit Research... Vista Outdoor (VSTO) initiated with an Outperform at RBC Capital... Weibo (WB) initiated with a Buy at Summit Research... YY Inc. (YY) initiated with a Buy at Summit Research... Youku Tudou (YOKU) initiated with a Hold at Summit Research... Zhaopin (ZPIN) initiated with a Hold at Summit Research.
08:19 EDTPTCTPTC Therapeutics to present Phase 1 clinical data from SMA program
PTC Therapeutics announced that Phase 1 clinical data from the company's joint development program with Roche and the SMA Foundation in spinal muscular atrophy, or SMA, will be presented at the 2015 American Academy of Neurology 67th Annual Meeting. As previously disclosed, findings from the Phase 1 study indicated that RG7800, an investigational oral therapy for SMA, showed a favorable safety profile and was well tolerated at all dose levels studied. In addition, proof of mechanism was demonstrated by a dose-dependent effect on Survival Motor Neuron 2, or SMN2, splicing towards the production of full length SMN2 mRNA. The Phase 1 study was a single ascending dose, placebo-controlled, double-blind study in 48 healthy volunteers testing single oral doses from 0.5 to 90 mg.
07:59 EDTPTCTJPMorgan sees range-bound as best case for PTC shares
JPMorgan believes the many triple-digit price targets for shares of PTC Therapeutics factor in unrealistic expectations for the company's pipeline in the absence of positive phase 3 data. The firm expects shares to be range bound in a best case with volatility likely amid continued takeover speculation. JPMorgan thinks a potential buyer is unlikely to pay "significantly" higher than current shares levels, particularly with the Phase 3 trial of ataluren in Duchenne muscular dystrophy in Q4. The firm raised its price target for PTC shares to $77 from $65 to reflect the MPS 1 opportunity for Translarna. It reiterates a Neutral rating on the stock.
05:47 EDTZPINZhaopin initiated with a Hold at Summit Research
Subscribe for More Information
April 16, 2015
11:04 EDTENPHEnphase Energy initiated with an Outperform at Avondale
Target $18.
10:00 EDTPTCTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:58 EDTPTCTPTC Therapeutics upgraded to Outperform at Cowen
As previously reported, Cowen upgraded PTC Therapeutics to Outperform from Market Perform ahead of its upcoming ACT-DMD data in the fourth quarter. The firm expects positive Phase 3 data after Phase 2 data established proof of concept. Cowen raised its price target to $120 from $70 on PTC Therapeutics to reflect the chance of success of Translarna in DMD.
07:55 EDTPTCTPTC Therapeutics upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
April 15, 2015
10:00 EDTENPHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:53 EDTQSIITopeka Capital to hold events at HIMSS '15
Subscribe for More Information
07:06 EDTATNMActinium Pharmaceuticals doses first patient in final cohort of Actimab-A trial
Subscribe for More Information
06:21 EDTENPHEnphase Energy initiated with an Overweight at JPMorgan
JPMorgan started shares of Enphase Energy with an Overweight rating saying the company offers pure-play exposure to the "rapid growth" in residential rooftop solar through 2016. The firm put a $16 price target on the shares.
April 14, 2015
05:29 EDTQSIINextGen, Milliman enter into agreement for analytics, risk scoring services
Subscribe for More Information
April 13, 2015
12:20 EDTTSETrinseo estimates preliminary Q1 sales $1B-$1.04B, consensus $1.16B
Estimates preliminary Q1 adjusted EBITDA $103M-$113M. Estimates adjusted EBITDA excluding inventory revaluation $145M-$155M. Sees Q1 free cash flow $13M-$19M, inclusive of $52M semi-annual interest payment on existing notes as well as "significant" inventory build ahead of planned turnarounds in Q2. Company estimates Q1 sales volume 1.39B pounds to 1.43B pounds. Information provided in a regulatory filing. "Information is derived from preliminary financial reports which management believes are reasonable and as a result is subject to change in connection with the completion of normal quarterly closing procedures and such changes could be material," said Trinseo.
07:31 EDTQSIIHealthcare Information & Management Systems Society to hold a conference
HIMSS 2015 is being held in Chicago on April 12-16.
07:29 EDTQSIILeerink to hold booth tours at HIMSS
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use